4th European Harm Reduction Conference, Bucharest Romania, 21-23 November 2018
Assessing the Impact of the Spring European Testing Week Pilot on Increasing Testing for Viral Hepatitis and HIV and Linking to Care. Presented by Ben Collins on behalf of the European Testing Week Working Group. POSTER

HIV Glasgow 2018, Glasgow Scotland 28 -31 October 2018

Missed Opportunities for HIV and Viral Hepatitis Testing in the Danish Health Care System presented by Marie Louise Jakobsen. POSTER

ID WEEK 2018, San Francisco, California 3 - 7 October 2018

Study of Single Nucleotide Polymorphisms Associated with HIV-1 Set-Point Viral Load in Antiretroviral Therapy-Naïve HIV-Positive Participants of the START study presented by Christina Ekenberg on behalf of the INSIGHT START Study Group. POSTER

Evaluation of MATCH: an Electronic Individual Patient-Focused Management System Aimed at Preventing Cytomegalovirus Disease Following Solid Organ Transplantation presented by Christina Ekenberg on behalf of the MATCH Program Study Group. POSTER
 
Development and Dynamics of Cytomegalovirus UL97 Ganciclovir Resistance Mutations in Transplant Recipients Detected by Next Generation Sequencing presented by Isabelle Lodding on behalf of the MATCH Program Study Group. POSTER

Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus (CMV) Infection and Disease in Solid Organ Transplant (SOT) Recipients presented by Mark Poulsen Khurana on behalf of the MATCH study group. POSTER

Development and validation of a cycle-specific risk score for febrile neutropenia during chemotherapy cycles 2-6 in patients with cancer: The CSRFENCE Score presetned by Theis Aagaard on behalf of PERSIMUNE. POSTER

HIV and Hepatitis Nordic conference, Stockholm, Sweden 26-28 September 2018

Review of HIV Testing Recommendations for HIV Indicator Conditions  in Guidelines from Danish National Health Authorities and Medical Specialties presented by Dorthe Raben. POSTER

The 7th International City Health Conference,Odesa, Ukraine 13-14 September

TB, HIV and Injecting Drug Use: Does the integration matter presented by Daria Podlekareva. PRESENTATION

The 22nd AIDS International Conference on HIV Science, Amsterdam The Netherlands 23-27 July 2018

Oral presentation:
Risk of HIV transmission through condomless sex in MSM couples with suppressive ART: The PARTNER2 Study extended results in gay men. presented by Alison Rodger on behalf of the PARTNER study
PRESENTATION  WEBCAST

Poster presentation:
The prevalence of impaired renal function in well-treated people living with HIV is low but remains higher than in uninfected controls. presented by Andreas Dehlbæk Knudsen on behalf of the Cocomo study.  POSTER

Data difficulties encountered in crowdsourcing information on legal & regulatory barriers to accessing HIV services (testing and care) for key populations across Europe, J Hows et al.  POSTER

Mortality differences after ART initiation in HIV-positive women from Europe, the Americas and Sub-Saharan Africa; 2000-2014 presented by Inma Jarrin for the Global Mortality Disparities in Women Working Group for IeDEA, EuroSIDA, CASCADE and COHERE in EuroCoord. POSTER

HIV testing strategies in Europe presented by Dorthe Raben on behalf of HIV in Europe.  POSTER

Uptake and effectiveness of two-drug compared to three-drug antiretroviral regimens among HIV-positive individuals in Europe presented by Annegret Pelchen-Matthews on behalf of the the EuroSIDA study.  POSTER

Symposia:

INTEGRATE Satellite Session, INTEGRATE
PROGRAM

Getting to 90: Addressing inequalities in the HIV continuum of care in Europe and Central Asia, European AIDS Clinical Society (EACS) and European Centre for Disease Prevention and Control (ECDC)
PROGRAM

• Addressing the second 90: How can treatment scale-up across the European region be accelerated? presented by Jend D Lundgren. PRESENTATION  

Harm reduction for people who inject drugs in Europe: Findings from European Joint Action HA-REACT, EU Health Programme 2014-2020 - European Joint Action HA-REACT
PROGRAM

• Access barriers and good practices to promote prevention and treatment services for PWID presented by Jeffrey V. Lazarus. PRESENTATION
• Joint Action on integrating prevention, testing and linkage to care strategies acros HIV, viral hepatitis, TB and STIs in Europe (INTEGRATE) presented by Dorthe Raben

Implementing the SDG agenda to leave no one behind: Innovations in Europe on the fast track to ending AIDS. UNAIDS and the European Commission
PROGRAM

• Integrated testing: Pilots in Eastern Europe EU member states presented by Dorthe Raben. PRESENTATION

The 25th Conference on Retroviruses and Opportunistic Infections, Boston Massachusetts, 4 - 7 March 2018

Oral presentations:
Serious clinical outcomes in HIV-positive persons with chronic kidney disease (CKD) presented by Lene Ryom on behalf of the DAD study PRESENTATION

Poster presentations:
Serum albumin as a long term predictor of serious non-AIDS events presented by Andreas Ronit on behalf of the DAD study POSTER


The International Liver Congress, Paris France, 11 - 15 April 2018

Poster presentations:
Efficacy and safety of IFN-free DAA therapy in HIV/HCV co-infected patients: Results from a pan-European study presented by Lars Peters POSTER

Patient monitoring of changes in the European policy response to viral hepatitis C treatment: Hep-CORE findings from 2016 to 2017 presented by Jeffrey Lazarus

Micro-elimination of hepatitis c among patients with congenital bleeding disorders in Slovenia presented by Mojca Maticic